Complete Filing Data
Caris Life Sciences, Inc. reported Temporary Equity Carrying Amount Attributable To Parent of $0.00 for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Caris Life Sciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Selling And Marketing Expense | $167.5M | $152.6M | $142.9M |
| Revenue From Contract With Customer Excluding Assessed Tax | $812.0M | $412.3M | $306.1M |
| Research And Development Expense | $101.6M | $113.9M | $116.9M |
| Other Nonoperating Income Expense | -$20.6M | -$349.0K | -$12.6M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $698.0K | -$8.0K | -$1.5M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $726.0K | -$15.0K | $180.0K |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $0.00 | $7.0K | -$1.7M |
| Operating Income Loss | $45.1M | -$257.1M | -$319.6M |
| Nonoperating Income Expense | -$113.2M | -$24.8M | -$21.9M |
| Net Income Loss Available To Common Stockholders Diluted | -$538.0M | -$378.3M | -$462.5M |
| Net Income Loss Available To Common Stockholders Basic | -$538.0M | -$378.3M | -$462.5M |
| Net Income Loss | -$68.1M | -$281.9M | -$341.4M |
| Interest Expense Nonoperating | $56.9M | $50.0M | $31.6M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$68.1M | -$281.9M | -$341.4M |
| General And Administrative Expense | $225.0M | $169.4M | $149.1M |
| Comprehensive Income Net Of Tax | -$67.4M | -$281.9M | -$342.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Selling And Marketing Expense | $41.3M | $42.3M | $36.8M | $38.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $216.8M | $181.4M | $101.6M | $100.0M |
| Research And Development Expense | $21.6M | $25.0M | $27.6M | $24.8M |
| Other Nonoperating Income Expense | -$89.0K | -$18.3M | $37.0K | -$141.0K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $71.0K | $424.0K | -$120.0K | $92.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $79.0K | $424.0K | -$120.0K | $92.0K |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income Loss | $32.6M | -$18.0M | -$60.8M | -$67.0M |
| Nonoperating Income Expense | -$8.3M | -$53.8M | -$6.9M | $825.0K |
| Net Income Loss Available To Common Stockholders Diluted | $24.3M | -$517.2M | -$92.4M | -$89.8M |
| Net Income Loss Available To Common Stockholders Basic | $24.3M | -$517.2M | -$92.4M | -$89.8M |
| Net Income Loss | $24.3M | -$71.8M | -$67.7M | -$66.2M |
| Interest Expense Nonoperating | $13.5M | $19.2M | $13.8M | $13.7M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $24.3M | -$71.8M | -$67.7M | -$66.2M |
| General And Administrative Expense | $52.0M | $64.4M | $40.9M | $41.1M |
| Comprehensive Income Net Of Tax | $24.4M | -$71.4M | -$67.8M | -$66.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $2.22B | $2.13B | $1.95B |
| Stockholders Equity | $577.3M | -$2.50B | -$2.14B | -$1.70B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $800.0M | $68.0M | $60.0M | $111.1M |
| Temporary Equity Dividends Adjustment | $384.4M | $0.00 | $0.00 | |
| Temporary Equity Accretion To Redemption Value Adjustment | $85.4M | $96.4M | $121.1M | |
| Gains Losses On Extinguishment Of Debt | -$19.9M | $0.00 | -$10.9M | |
| Amortization Of Debt Discount Premium | $12.8M | $7.1M | $5.4M | |
| Temporary Equity Accretion To Redemption Value | $85.4M | $96.4M | $121.1M | |
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $85.4M | $96.4M | $121.1M | |
| Contract Equity Interest Income From Related Party Promissory Notes | $128.0K | $755.0K | $732.0K | |
| Operating Lease Right Of Use Asset Amortization Expense | $5.6M | $5.6M | $4.3M | |
| Finance Lease Principal Payments | $106.0K | $157.0K | $743.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $732.0M | $8.0M | -$51.1M | |
| Warrant Liabilities Noncurrent | $0.00 | $91.6M | ||
| Treasury Stock Shares Acquired | 1.4M | 0.00 | ||
| Treasury Stock Common Value | $16.9M | $330.0K | ||
| Treasury Stock Common Shares | 1.6M | 182.5K | ||
| Temporary Equity Value Conversion Of Stock In Connection With Initial Public Offering | $2.39B | -$50.0M | ||
| Temporary Equity Liquidation Preference | $1.95B | $1.78B | ||
| Retained Earnings Accumulated Deficit | -$2.55B | -$2.47B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $2.25B | $2.20B | $2.17B | $2.15B | |
| Stockholders Equity | $478.4M | $452.9M | -$2.60B | -$2.44B | -$2.36B | -$2.27B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $757.0M | $722.7M | $109.0M | $180.2M | ||
| Temporary Equity Dividends Adjustment | $0.00 | $384.4M | $0.00 | $0.00 | ||
| Temporary Equity Accretion To Redemption Value Adjustment | $0.00 | $61.0M | $24.7M | $23.6M | ||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$17.9M | $0.00 | $0.00 | ||
| Amortization Of Debt Discount Premium | $2.5M | $7.8M | $1.8M | $1.7M | ||
| Temporary Equity Accretion To Redemption Value | $61.0M | $24.7M | $23.6M | |||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $61.0M | $24.7M | $23.6M | |||
| Contract Equity Interest Income From Related Party Promissory Notes | $189.0K | $186.0K | ||||
| Operating Lease Right Of Use Asset Amortization Expense | ||||||
| Finance Lease Principal Payments | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | ||||||
| Warrant Liabilities Noncurrent | $0.00 | $0.00 | ||||
| Treasury Stock Shares Acquired | ||||||
| Treasury Stock Common Value | $16.9M | $16.9M | ||||
| Treasury Stock Common Shares | 1.6M | 1.6M | ||||
| Temporary Equity Value Conversion Of Stock In Connection With Initial Public Offering | -$380.0K | $2.39B | ||||
| Temporary Equity Liquidation Preference | ||||||
| Retained Earnings Accumulated Deficit | -$2.63B | -$2.66B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Depreciation Depletion And Amortization | $22.6M | $48.9M | $49.0M |
| Share Based Compensation | $70.0M | $18.6M | $15.2M |
| Proceeds From Stock Options Exercised | $7.6M | $1.5M | $1.9M |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $0.00 | $61.4M | $300.5M |
| Proceeds From Issuance Of Warrants | $10.3M | $0.00 | $0.00 |
| Proceeds From Issuance Of Secured Debt | $0.00 | $200.0M | $191.3M |
| Proceeds From Issuance Initial Public Offering | $528.5M | $0.00 | $0.00 |
| Proceeds From Convertible Debt | $27.9M | $0.00 | $0.00 |
| Payments To Acquire Property Plant And Equipment | $16.3M | $8.4M | $22.3M |
| Payments Related To Tax Withholding For Share Based Compensation | $18.6M | $0.00 | $0.00 |
| Payments Of Stock Issuance Costs | $7.7M | $1.1M | $0.00 |
| Payments Of Debt Restructuring Costs | $4.0M | $0.00 | $0.00 |
| Payments For Repurchase Of Common Stock | $113.0K | $0.00 | $0.00 |
| Net Cash Provided By Used In Operating Activities | $83.2M | -$245.2M | -$276.1M |
| Net Cash Provided By Used In Investing Activities | -$16.3M | $52.9M | $214.8M |
| Net Cash Provided By Used In Financing Activities | $665.0M | $200.3M | $10.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.2M | $1.4M | -$4.5M |
| Increase Decrease In Other Noncurrent Assets | -$48.0K | -$121.0K | $588.0K |
| Increase Decrease In Materials And Supplies | $20.8M | -$5.5M | $4.4M |
| Increase Decrease In Accrued Liabilities | $11.5M | $803.0K | $1.3M |
| Increase Decrease In Accounts Receivable | $29.8M | $33.8M | $15.1M |
| Increase Decrease In Accounts Payable | $11.0M | -$226.0K | $7.2M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $130.0K | -$4.0K | $62.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Depreciation Depletion And Amortization | $4.9M | $6.4M | $10.5M | $11.6M |
| Share Based Compensation | ||||
| Proceeds From Stock Options Exercised | ||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | ||||
| Proceeds From Issuance Of Warrants | ||||
| Proceeds From Issuance Of Secured Debt | ||||
| Proceeds From Issuance Initial Public Offering | ||||
| Proceeds From Convertible Debt | ||||
| Payments To Acquire Property Plant And Equipment | ||||
| Payments Related To Tax Withholding For Share Based Compensation | ||||
| Payments Of Stock Issuance Costs | ||||
| Payments Of Debt Restructuring Costs | ||||
| Payments For Repurchase Of Common Stock | ||||
| Net Cash Provided By Used In Operating Activities | ||||
| Net Cash Provided By Used In Investing Activities | ||||
| Net Cash Provided By Used In Financing Activities | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | ||||
| Increase Decrease In Other Noncurrent Assets | ||||
| Increase Decrease In Materials And Supplies | ||||
| Increase Decrease In Accrued Liabilities | ||||
| Increase Decrease In Accounts Receivable | ||||
| Increase Decrease In Accounts Payable | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 751.1M | 734.1M | 734.1M | 703.1M |
| Weighted Average Number Of Shares Outstanding Basic | 167.2M | 35.5M | 34.9M | |
| Weighted Average Number Of Diluted Shares Outstanding | 167.2M | 35.5M | 34.9M | |
| Earnings Per Share Diluted | $-3.22 | $-10.66 | $-13.24 | |
| Earnings Per Share Basic | $-3.22 | $-10.66 | $-13.24 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 100.0M | 0.00 | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 2.80B | 1.15B | ||
| Temporary Equity Shares Issued | 751.1M | 734.1M | ||
| Temporary Equity Shares Authorized | 787.4M | 764.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | 734.1M | 734.1M | 734.1M | 734.1M | ||
| Weighted Average Number Of Shares Outstanding Basic | 282.1M | 64.9M | 35.6M | 35.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 297.2M | 64.9M | 35.6M | 35.4M | ||
| Earnings Per Share Diluted | $0.08 | $-7.97 | $-2.59 | $-2.54 | ||
| Earnings Per Share Basic | $0.09 | $-7.97 | $-2.59 | $-2.54 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 100.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | |||||
| Common Stock Shares Authorized | 2.80B | |||||
| Temporary Equity Shares Issued | ||||||
| Temporary Equity Shares Authorized |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $7.6M | $1.5M | $1.9M |
| Interest Income Other | $16.5M | $7.1M | $11.3M |
| Fair Value Adjustment Of Financial Instruments | -$52.3M | $18.5M | $11.1M |
| Costs And Expenses | $766.9M | $669.4M | $625.7M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $70.0M | $18.6M | $15.2M |
| Stock Issued During Period Value Early Exercise Of Stock Options | $327.0K | $5.0M | $5.0M |
| Other Noncash Income Expense | -$1.2M | -$4.0M | $1.3M |
| Changes In Fair Value Of Financial Instruments | -$52.3M | $18.5M | $11.1M |
| Supplies | $63.6M | $39.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $1.2M | $1.2M | $657.0K | $393.0K |
| Interest Income Other | $7.4M | $1.6M | $1.7M | $2.6M |
| Fair Value Adjustment Of Financial Instruments | -$2.1M | -$17.9M | $5.1M | $12.0M |
| Costs And Expenses | $184.2M | $199.4M | $162.5M | $167.1M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $13.7M | $28.3M | $4.7M | $4.5M |
| Stock Issued During Period Value Early Exercise Of Stock Options | $327.0K | $5.0M | ||
| Other Noncash Income Expense | ||||
| Changes In Fair Value Of Financial Instruments | ||||
| Supplies | $49.3M | $40.6M |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.